Finance

Beta
Lists
249420:KRX
Il Dong Pharmaceutical Co Ltd
â‚©18,310.00
-3.73%
(-710.00) 1D
Jun 19, 3:30:24 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 249420...
Open
â‚©18,830
High
â‚©18,860
Low
â‚©17,900
Mkt. cap
579.30B
Avg. vol.
232.58K
Volume
127.44K
Dividend
1.09%
Quarterly dividend
â‚©50
Ex-dividend date
Mar 30, 2026
P/E ratio
16.25
52-wk high
â‚©45,050
52-wk low
â‚©12,400
EPS
â‚©1,127
Shares outstanding
31.64M
No. of employees
1K
Open
â‚©18,830
High
â‚©18,860
Low
â‚©17,900
Mkt. cap
579.30B
Avg. vol.
232.58K
Volume
127.44K
Dividend
1.09%
Quarterly dividend
â‚©50
Ex-dividend date
Mar 30, 2026
P/E ratio
16.25
52-wk high
â‚©45,050
52-wk low
â‚©12,400
EPS
â‚©1,127
Shares outstanding
31.64M
No. of employees
1K
News stories
From sources across the web
About Il Dong Pharmaceutical Co Ltd
CEOWung Seop Yoon
Employees1.06K
Founded1941
Headquarters-
SectorPharmaceutical industry
Websiteildong.com
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
138.48B
145.46B
147.02B
142.00B
Cost of goods sold
84.75B
86.98B
90.12B
83.46B
Cost of revenue
84.75B
86.98B
90.12B
83.46B
Research and development expenses
9.11B
9.38B
9.15B
9.06B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
42.19B
40.49B
38.46B
38.99B
Operating expense
53.08B
51.72B
51.15B
49.13B
Total operating expenses
137.83B
138.70B
141.27B
132.59B
Operating income
651.40M
6.76B
5.75B
9.41B
Other non operating income
3.23B
16.98B
2.25B
493.34M
EBT including unusual items
-3.77B
28.30B
6.09B
9.20B
EBT excluding unusual items
737.86M
21.28B
6.09B
9.06B
Income tax expense
124.89M
6.81B
489.84M
1.82B
Effective tax rate
-3.31%
24.07%
8.04%
19.79%
Other operating expenses
322.17M
446.84M
249.24M
261.46M
Net income
-3.01B
22.41B
7.24B
8.27B
Net profit margin
-2.17%
15.40%
4.92%
5.82%
Earnings per share
-
-
-
-
Interest and investment income
326.89M
172.88M
102.81M
1.01B
Interest expense
-3.70B
-2.77B
-1.93B
-1.82B
Net interest expenses
-3.38B
-2.60B
-1.82B
-811.17M
Depreciation and amortization charges
1.27B
1.25B
1.20B
1.07B
EBITDA
6.38B
12.46B
11.08B
14.91B
Gain or loss from assets sale
1.97B
140.84M
3.66M
10.12M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer